Novo Nordisk Eyes a Bigger Piece of the Diabetes Market

Novo Nordisk wants to take its partnership with Biocorp to the next level. The Bagsværd, Denmark-based company said on Monday that it is in exclusive negotiations with Bio Jag, Biocorp’s main shareholder in a deal with a value of $164 million.